The chemoprevention of prostate cancer and the Prostate Cancer Prevention Trial.
Brawley
O W
OW
Thompson
I M
IM
D058891:5-alpha Reductase Inhibitors; D000728:Androgens / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018890:Chemoprevention; D003131:Combined Modality Therapy; D018450:Disease Progression; D000518:Eflornithine / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000201:enzymology / Q000473:pathology / Q000517:prevention & control*; D012307:Risk Factors; D014815:Vitamins / Q000627:therapeutic use
D058891:5-alpha Reductase Inhibitors; D000728:Androgens; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D014815:Vitamins; D018120:Finasteride; D000518:Eflornithine